Patent details

EP2083837 Title: THERAPEUTIC USE OF AT LEAST ONE BOTULIC NEUROTOXIN IN THE TREATMENT OF PAIN INDUCED BY AT LEAST ONE ANTINEOPLASTIC AGENT

Basic Information

Publication number:
EP2083837
PCT Application Number:
PCT/FR/2007/001773
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078664463
PCT Publication Number:
WO/2008/059126
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
THERAPEUTIC USE OF AT LEAST ONE BOTULIC NEUROTOXIN IN THE TREATMENT OF PAIN INDUCED BY AT LEAST ONE ANTINEOPLASTIC AGENT
French Title of Invention:
UTILISATION THERAPEUTIQUE D'AU MOINS UNE NEUROTOXINE BOTULIQUE DANS LE TRAITEMENT DE LA DOULEUR INDUITE PAR AU MOINS UN AGENT ANTI-CANCEREUX
German Title of Invention:
VERWENDUNG VON BOTULINUM NEUROTOXIN ZUR BEHANDLUNG VON ANTIIKREBSMITTEL- INDUZIERTEM SCHMERZ
SPC Number:

Dates

Filing date:
26/10/2007
Grant date:
07/01/2015
EP Publication Date:
07/01/2015
PCT Publication Date:
22/05/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/08/2009
EP B1 Publication Date:
07/01/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/10/2015
Expiration date:
26/10/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/10/2007
 
 

Name:
IPSEN PHARMA S.A.S.
Address:
65, Quai Georges Gorse, 92100 Boulogne-Billancourt, France (FR)

Inventor

1

Name:
FAVRE Christine
Address:
France (FR)

2

Name:
CHABRIER DE LASSAUNIERE Pierre-Etienne
Address:
France (FR)

3

Name:
AUGUET Michel
Address:
France (FR)

Priority

Priority Number:
0609435
Priority Date:
27/10/2006
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 35/74;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages